| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2008 | WO2008015250A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | WO2008015241A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2008015226A1 Compositions and methods for treating diabetes and neuropsychological dysfunction |
| 02/07/2008 | WO2008015220A1 Granule and orally disintegrating tablet comprising oxycodone |
| 02/07/2008 | WO2008015202A2 Anticonvulsive pharmaceutical compositions |
| 02/07/2008 | WO2008015196A1 5-,7-bis-substituted imidazo[1,2-a]pyridines |
| 02/07/2008 | WO2008015190A2 Treatment and prevention of excessive scarring |
| 02/07/2008 | WO2008015163A1 Treatment of pain |
| 02/07/2008 | WO2008015139A2 Inhibitors of zinc proteases thioaryl substituted and their use |
| 02/07/2008 | WO2008015137A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/07/2008 | WO2008015125A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/07/2008 | WO2008015081A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | WO2008015028A1 Uses and compositions comprising mirnas |
| 02/07/2008 | WO2008015021A1 Treatment of endocrine dysfunction using iron chelators |
| 02/07/2008 | WO2008015018A1 Delayed-release glucocorticoid treatment of rheumatoid disease |
| 02/07/2008 | WO2008015001A1 Rho/rock/p13/akt kinase inhibitors for the treatment of diseases associated with protozoan parasites |
| 02/07/2008 | WO2008014888A2 Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 02/07/2008 | WO2008014824A1 Antiviral use of cationic surfactant |
| 02/07/2008 | WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2008014821A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors |
| 02/07/2008 | WO2008014815A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2008014814A1 Combination andolast/glucocorticoids |
| 02/07/2008 | WO2008014733A1 Medicament for lct poisoning |
| 02/07/2008 | WO2008014722A1 Prenyl flavonoids,their preparation and use |
| 02/07/2008 | WO2008014686A1 Formulation containing low molecular heparin for intraarticular injection |
| 02/07/2008 | WO2008014685A1 Formulation containing trehalose for intraarticular injection |
| 02/07/2008 | WO2008014661A1 Tetrahydroprotoberberine compounds, their manufacture, medicinal composition and uses. |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2008014602A1 Quinoline derivatives |
| 02/07/2008 | WO2008014564A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | WO2008014563A1 Methods and compositions for promoting activity of anti-cancer therapies |
| 02/07/2008 | WO2008002853A3 Phenylacetic acid derivatives as cox-2 inhibitors |
| 02/07/2008 | WO2008002544A3 Unit dosage forms of temozolomide |
| 02/07/2008 | WO2008000777A3 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
| 02/07/2008 | WO2007149907A3 Pyrazoloquinazolinones as parp inhibitors |
| 02/07/2008 | WO2007147861A3 Sustained release formulations of aromatase inhibitors |
| 02/07/2008 | WO2007147085A3 Treatment of wound using aganocides and negative pressure |
| 02/07/2008 | WO2007146758A3 Novel mch receptor antagonists |
| 02/07/2008 | WO2007146719A3 2-aminocarbonylphenylamino-2-phenylacetamides as factor viia inhibitors useful as anticoagulants |
| 02/07/2008 | WO2007146550A3 Alkene piperidine derivatives as antiviral agents |
| 02/07/2008 | WO2007146440A3 Glucan preparations |
| 02/07/2008 | WO2007144487A3 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses |
| 02/07/2008 | WO2007143526A3 Substituted tetrahydroimidazonaphthyridines and methods |
| 02/07/2008 | WO2007143483A3 Combination of pazopanib and lapatinib for treating cancer |
| 02/07/2008 | WO2007143425A3 Treatment of hot flashes using muscarinic receptor antagonists |
| 02/07/2008 | WO2007143422A3 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 02/07/2008 | WO2007143086A3 Delivery method |
| 02/07/2008 | WO2007142904A3 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
| 02/07/2008 | WO2007140385A3 Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| 02/07/2008 | WO2007140189A3 Preparation and utility of substituted carboxylic acid compounds |
| 02/07/2008 | WO2007139753A3 Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
| 02/07/2008 | WO2007138472A3 Triazolopyridazine derivatives |
| 02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
| 02/07/2008 | WO2007135547A3 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
| 02/07/2008 | WO2007135518A3 Use of choline-based preparations for the treatment of tinnitus |
| 02/07/2008 | WO2007135505A3 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 02/07/2008 | WO2007133796A3 Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist |
| 02/07/2008 | WO2007132178A3 Combination therapy product and uses thereof |
| 02/07/2008 | WO2007128478A3 Pharmaceutical composition |
| 02/07/2008 | WO2007127375A3 Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| 02/07/2008 | WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/07/2008 | WO2007121484A3 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 02/07/2008 | WO2007120930A3 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 02/07/2008 | WO2007120523A8 6-(aminoalkyl)indazoles |
| 02/07/2008 | WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 02/07/2008 | WO2007117398B1 Non-peptidic molecules for detecting and treating tumors |
| 02/07/2008 | WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders |
| 02/07/2008 | WO2007111954A3 Purine compounds and methods of use thereof |
| 02/07/2008 | WO2007111806A3 Cyclopentane heptanoic acid compounds for reducing body fat |
| 02/07/2008 | WO2007109596A3 Heteroaryl dihydroindolones as kinase inhibitors |
| 02/07/2008 | WO2007103308A3 Heterobicyclic pyrazole compounds and methods of use |
| 02/07/2008 | WO2007102074A3 Salts of quetiapine |
| 02/07/2008 | WO2007099431A3 An aqueous liquid pharmaceutical compositions of gatifloxacin |
| 02/07/2008 | WO2007098503A3 Aliskiren nitrate salt |
| 02/07/2008 | WO2007082864A3 Use of chavicol as an antiseptic |
| 02/07/2008 | WO2007073560A3 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 02/07/2008 | WO2007073424A8 Pure rocuronium bromide |
| 02/07/2008 | WO2007070506B1 Diaza heterocyclic sulfonamide derivatives and their uses |
| 02/07/2008 | WO2007067623A3 Biocompatible tissue sealants and adhesives |
| 02/07/2008 | WO2007067622A3 Carbodiimide crosslinking of functionalized polethylene glycols |
| 02/07/2008 | WO2007054309A3 Use of clodronic acid for the treatment of navicular syndrome |
| 02/07/2008 | WO2007035722B1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 02/07/2008 | WO2006105304A8 Phenyl and pyridyl lta4h modulators |
| 02/07/2008 | WO2005107668A3 Dressing and method of treatment for a wound |
| 02/07/2008 | WO2005046568A3 Process for manufacture of metoprolol and salts thereof |
| 02/07/2008 | WO2004000213A3 Method for growing human organs, treating diseases, and increasing longevity |
| 02/07/2008 | US20080033207 Preparation of R-5- (2-(2-Ethoxyphenoxyetylamino) -2-Methoxybenzen-Sulphonamide Hydrochloride of High Chemical |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033156 Short interfering nucleic acid (siNA) molecule and a polyamine compound having guanidinium, amine, or histidyl end groups and optionally containing polyether groups; biodrug delivery |
| 02/07/2008 | US20080033060 Use Of A Compound Modulating At Least One Receiver Selected In A Group Comprising An Interleukin 8 Type B Receptor And Pacap-1 Receptor For Porparing A Pharmaceutical Composition For Rosacea Treatment |
| 02/07/2008 | US20080033058 Personal care compositions that deposit hydrophilic benefit agents |
| 02/07/2008 | US20080033057 Hexahydro-isoalpha acid based protein kinase modulation cancer treatment |
| 02/07/2008 | US20080033056 Xanthohumol based protein kinase modulation cancer treatment |
| 02/07/2008 | US20080033055 Low-molecular-weight alkyl esters as a replacement solvents for dimethylacetamide in the synthesis of curcumin and its demethoxy-/bisdemethoxy derivatives; fragrant esters, isobutyl acetate/ethyl butyrate; low boiling; nontoxic reagents; recoverability; cost efficiency; environmentally friendly; purity |
| 02/07/2008 | US20080033054 Process for preparing memantine hydrochloride substantially free of impurities |
| 02/07/2008 | US20080033053 Cross-Reference To Related Applications |
| 02/07/2008 | US20080033052 Dermal anesthetic compounds |